# SODIUM PHOSPHATES

NDC: 80830-2310
Generic name: sodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic, heptahydrate
Labeler / Manufacturer: Amneal Pharmaceuticals Private Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20261020

FDA application: ANDA218274

## Active ingredients

- SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE: 276 mg/mL
- SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE: 268 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"80830-2310"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=80830-2310